非无精子症男性因素不育中睾丸精子提取与射精精子的比较
该回顾性队列研究基于梅奥诊所辅助生殖技术数据库,纳入2016至2019年接受卵胞浆内单精子注射的非无精子症男性因素不育夫妇,比较睾丸精子提取(TESE)与射精精子的结局。结果显示,与射精精子相比,TESE未改善流产率或活产率,且与受精率下降和囊胚数减少相关。
要点
- TESE组受精率较射精精子组降低20%(60.0% vs. 80.6%)。
- TESE组囊胚数仅为射精精子组的一半(2个 vs. 4个)。
- TESE未改善流产率(11% vs. 9%)或活产率(50.0% vs. 31.3%)。
核心结论
- 对于少精子症男性因素不育患者,使用TESE样本与射精精子相比未改善ICSI结局。
研究设计与样本
- 回顾性队列研究,使用梅奥诊所辅助生殖技术数据库,单学术中心。
主要发现
- 两组年龄、体重指数和卵巢储备相似。
- 基线精子参数相似:总活动精子(射精精子组5.4 vs. TESE组3.6百万/射精),但射精精子组基线活动力更高(40% vs. 29%)。
- 两组获成熟卵母细胞总数相似,但TESE与受精率降低20%相关(60.0% vs. 80.6%),囊胚数减半(2个 vs. 4个)。
- 与射精精子相比,TESE未改善流产率(11% vs. 9%)或活产率(50.0% vs. 31.3%)。
临床怎么用
- 对于少精子症男性因素不育患者,选择TESE前应权衡其未改善活产率且降低受精率和囊胚数的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the potential benefit of testicular sperm compared with ejaculated sperm for men with oligospermia. DESIGN: After exemption from institutional review board approval, we performed a retrospective cohort study using the Mayo Clinic Assisted Reproductive Technology database. SETTING: Single academic center. PATIENT(S): Couples with nonazoospermic male factor infertility (total motile sperm <25 million per ejaculate) undergoing intracytoplasmic sperm injection with sperm obtained by testicular sperm extraction (TESE) or ejaculated sperm between 2016 and 2019. INTERVENTION(S): In vitro fertilization, Intracytoplasmic sperm injection, TESE. MAIN OUTCOME MEASURE(S): The primary outcome was live birth rate. The secondary outcomes were fertilization rate, blastulation rate, pregnancy rate, and miscarriage rate. RESULT(S): Subjects in the two groups were similar in age, body mass index, and ovarian reserve. Baseline sperm parameters were similar in the two groups: total motile sperm (5.4 in the ejaculate sperm group vs. 3.6 million motile per ejaculate), except that baseline motility was higher in the group that used ejaculated sperm (40% vs. 29%). The total number of mature oocytes retrieved was similar in the two groups, but the use of TESE was associated with a 20% decrease in fertilization (60.0% vs. 80.6%) and half the number of blastocyst embryos (two vs. four) compared with ejaculated sperm. Compared with ejaculated sperm, use of TESE did not improve the miscarriage rate (11% vs. 9%) or the live birth rate (50.0% vs. 31.3%). CONCLUSION(S): Patients with male factor infertility and oligozoospermia did not have improved ICSI outcomes with the use of TESE samples compared with ejaculated sperm.
引用
- Kendall Rauchfuss LM, Kim T, Bleess JL, et al. Testicular sperm extraction vs. ejaculated sperm use for nonazoospermic male factor infertility. Fertil Steril. 2021. PMID: 34233843. doi:10.1016/j.fertnstert.2021.05.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。